Tomasz M. Beer

1995–2024 年に発表

別表記
Tomasz M Beer
123
論文数
32,194
被引用数
81
h 指数
121
i10 指数

被引用数

Tomasz M. Beer の年別被引用数1993 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 3 件1997 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 5 件2001 年: 被引用 2 件2002 年: 被引用 10 件2003 年: 被引用 10 件2004 年: 被引用 30 件2005 年: 被引用 39 件2006 年: 被引用 60 件2007 年: 被引用 55 件2008 年: 被引用 81 件2009 年: 被引用 89 件2010 年: 被引用 137 件2011 年: 被引用 170 件2012 年: 被引用 149 件2013 年: 被引用 202 件2014 年: 被引用 228 件2015 年: 被引用 260 件2016 年: 被引用 303 件2017 年: 被引用 341 件2018 年: 被引用 401 件2019 年: 被引用 1,154 件2020 年: 被引用 1,323 件2021 年: 被引用 1,488 件2022 年: 被引用 1,180 件2023 年: 被引用 964 件2024 年: 被引用 1,656 件2025 年: 被引用 709 件2026 年: 被引用 24 件1994 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,975 件、この内訳の 27.7%中国: 引用元論文 1,172 件、この内訳の 8.2%イギリス: 引用元論文 940 件、この内訳の 6.6%カナダ: 引用元論文 791 件、この内訳の 5.5%ドイツ: 引用元論文 790 件、この内訳の 5.5%イタリア: 引用元論文 726 件、この内訳の 5.1%フランス: 引用元論文 556 件、この内訳の 3.9%オーストラリア: 引用元論文 523 件、この内訳の 3.6%日本: 引用元論文 414 件、この内訳の 2.9%オランダ: 引用元論文 414 件、この内訳の 2.9%スペイン: 引用元論文 405 件、この内訳の 2.8%スイス: 引用元論文 376 件、この内訳の 2.6%
0%27.7%その他 22.7%

分野

  • Medicine71.2%
  • Biochemistry, Genetics and Molecular Biology21.3%
  • Immunology and Microbiology3.4%
  • Engineering0.6%
  • Computer Science0.6%
  • Materials Science0.4%
  • その他2.5%

トピック

  • Prostate Cancer Treatment and Research16.3%
  • Prostate Cancer Diagnosis and Treatment7.2%
  • Radiopharmaceutical Chemistry and Applications5.4%
  • Cancer Immunotherapy and Biomarkers4.1%
  • Cancer, Lipids, and Metabolism2.8%
  • Cancer Genomics and Diagnostics2.6%
  • その他61.6%

共著者

全論文

検索で開く
  1. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 2,598

  2. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  3. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 3,031

  4. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study

    著者: , , , , , , , , , , - The Lancet 2023 被引用: 361

  5. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Small - Journal of Clinical Oncology 2018 被引用: 812

  6. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Chou, Haolong Li, Rajdeep Das, Hui Li, Ruhollah Moussavi-Baygi, Hani Goodarzi, Luke A. Gilbert, Primo N. Lara, Christopher P. Evans, Theodore C. Goldstein, Joshua M. Stuart, Scott A. Tomlins, Daniel E. Spratt, R. Keira Cheetham, Donavan T. Cheng, Kyle Kai‐How Farh, Julian Gehring, Jörg Hakenberg, Arnold Liao, Philip G. Febbo, John Shon, Brad Sickler, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, Felix Y. Feng - Cell 2018 被引用: 759

  7. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 1,496

  8. Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , - Science 2009 被引用: 2,332

  9. Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 754

  10. The DNA methylation landscape of advanced prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, M. Yvonne Kim, Lawrence Fong, Daniel E. Spratt, Todd M. Morgan, Rohit Bose, Franklin W. Huang, Hui Li, Lisa N. Chesner, Tanushree Shenoy, Hani Goodarzi, Irfan A. Asangani, Shahneen Sandhu, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phillip G. Febbo, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Wilbert Zwart, J Costello, Jianhua Luo, Scott A. Tomlins, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Luke A. Gilbert, Paul C. Boutros, Kyle Kai‐How Farh, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, David A. Quigley, Felix Y. Feng - Nature Genetics 2020 被引用: 353

  11. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  12. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

    著者: , , , , , , , - Nature Medicine 2012 被引用: 784

  13. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 2,241

  14. Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial

    著者: , , , , , , , , , - European Urology 2020 被引用: 163

  15. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

    著者: , , , , , , , , , , , , , , , , , , , , - European Urology 2016 被引用: 419

  16. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2017 被引用: 420

  17. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 被引用: 175

  18. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  19. Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Celestia S. Higano, Matti Aapro, Michael Krainer, Stephan Hruby, Johannes Meran, S. Polyakov, Jean‐Pascal Machiels, Thierry Roumeguère, Koen Ackaert, Nicolaas Lumen, Thierry Gil, Velko Minchev, Antoaneta Tomova, Borislav D. Dimitrov, Marchela Koleva, Antonio Juretić, Ana Fröbe, Željko Vojnović, Martin Drabek, L. Jarolím, Tomáš Büchler, Eva Kindlová, Jan Schraml, Milada Zemanová, Prausova Jana, Bohuslav Melichar, Martina Chodacká, Jan Jansa, Gedske Daugaard, Nicolas Delonchamps, Brigitte Duclos, Stéphane Culine, G. Deplanque, Sylvestre Le Moulec, Peter Hammerer, Gerald Rodemer, Manuel Ritter, Axel S. Merseburger, Marc‐Oliver Grimm, Ilija Damjanoski, Manfred Wirth, Martin Burmester, Kurt Miller, Jan Herden, Bastian Keck, Christian Wuelfing, Alexander Winter, Martin Boegemann, Ingo Kausch von Schmeling, Paolo Fornara, E. Jaeger, G. Bodoky, Zsuzsanna Pápai, Géza Böszörményi-Nagy, Paola Vanella, Héctor Soto Parrà, Rodolfo Passalacqua, Francesco Ferraù, Michele Maio, Lucia Fratino, Enrico Cortesi, Gunta Purkalne, Jolita Asadauskienė, Rasa Jančiauskienė, Skaistė Tulytė, Alvydas Česas, Marco B. Polée, Brigitte C.M. Haberkorn, Fons van de Eertwegh, Pieter van den Berg ほか 83 名 - JAMA Oncology 2022 被引用: 90

  20. Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 被引用: 268

  21. LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

    著者: , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 被引用: 229

  22. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice

    著者: , , , , , , , , , , , , , , , - Cancers 2021 被引用: 104

  23. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 被引用: 643

  24. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

    著者: , , , , , , , , , , , , , , - Investigational New Drugs 2014 被引用: 222